Showing results (291-300 of 3,348) with videos related to

Sort By:
Pageof 335
Pharmacoeconomics|March 3, 2001
Association between abciximab and length of stay in intensive care for patients undergoing percutaneous coronary intervention. A 2-stage econometric model in a naturalistic settingM J Lage, B L Barber, M Bala, et al.
Pharmacoeconomics|April 17, 2001
Influenza. Cost of illness and considerations in the economic evaluation of new and emerging therapiesP Cram, S G Blitz, A Monto, et al.
Pharmacoeconomics|April 17, 2001
Workplace productivity. A review of the impact of migraine and its treatmentP Stang, R Cady, A Batenhorst, et al.
Pharmacoeconomics|April 17, 2001
Cost of treatment for onychomycosis. Data from a 9-month observational studyD M Stier, C Henke, J Schein, et al.
Pharmacoeconomics|April 17, 2001
Rivastigmine. A pharmacoeconomic review of its use in Alzheimer's diseaseH M Lamb, K L Goa
Pharmacoeconomics|October 13, 2001
Pharmacoeconomic fellowships: the need for outcome measuresV Maio, T K Girts, J H Lofland, et al.
Pharmacoeconomics|October 13, 2001
A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settingsD P Lubeck
Pharmacoeconomics|October 13, 2001
Cost effectiveness in Canada of a multidrug prepackaged regimen (Hp-PAC)+ for Helicobacter pylori eradicationK Agro, G Blackhouse, R Goeree, et al.
Pharmacoeconomics|July 24, 2001
Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDST A Lee, S D Sullivan, D L Veenstra, et al.
Pharmacoeconomics|July 24, 2001
Cost effectiveness of nasal calcitonin in postmenopausal women: use of Cochrane Collaboration methods for meta-analysis within economic evaluationD Coyle, A Cranney, K M Lee, et al.
Pageof 335